(Q62062413)

English

Postmarketing Study of Empliciti in Korean Patients With Multiple Myeloma

clinical trial

Statements

Empliciti (Elotuzumab) Postmarketing Surveillance in Korean Patients With Multiple Myeloma (English)
0 references
31 January 2019
0 references
10 February 2023
0 references
96
0 references
19 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit